Skip to main content
Dolby Laboratories, Inc. logo

Dolby Laboratories, Inc. — Investor Relations & Filings

Ticker · DLB ISIN · US25659T1079 LEI · 549300X04FB2QPCJ5J24 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,701 across all filing types
Latest filing 2016-02-05 Director's Dealing
Country US United States of America
Listing US DLB

About Dolby Laboratories, Inc.

https://www.dolby.com/

Dolby Laboratories, Inc. specializes in creating audio, visual, and voice technologies designed to enhance entertainment and communications. Originally known for its audio noise reduction and encoding systems, the company develops and licenses a broad portfolio of technologies. Key offerings include Dolby Atmos for immersive sound and Dolby Vision for high-dynamic-range (HDR) imaging, which have become standards in content creation and playback. These technologies are integrated into a wide array of applications, including cinema, home entertainment, mobile devices, broadcast, music, and gaming, with the goal of transforming the science of sight and sound into more spectacular and immersive experiences for consumers.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2016-02-05 English
FORM 4 SUBMISSION
Director's Dealing
2016-02-05 English
FORM 4 SUBMISSION
Director's Dealing
2016-02-05 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a letter from Dolby Laboratories, Inc. to the SEC Division of Corporation Finance responding to comments on the company's Form 10-K for the fiscal year ended September 25, 2015. It references the 10-K filing and addresses specific financial statement notes, particularly income taxes. The letter includes detailed explanations about tax rates and allocations, which are typical of comment letters responding to SEC staff review of an annual report. The document is not the 10-K report itself but a correspondence related to it. Given the nature of the document as a response letter to SEC comments on the 10-K, it fits best under Regulatory Filings (RNS), which is the fallback category for such correspondence and does not contain the full report or financial statements itself.
2016-02-04 English
FORM 4 SUBMISSION
Director's Dealing
2016-02-04 English
FORM 4 SUBMISSION
Director's Dealing
2016-02-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.